Pau d'Arco and Cancer Research: Benefits and Safety
Written by Julien Griffault, Co-Founder, Taheebo Wellness Tea — Published April 2026 | Last updated May 2026
Does Taheebo Tea help with Cancer? This is a question we get asked often. Julien, the co-founder of Taheebo Wellness Tea, used Pau d'Arco as part of his daily regimen to recover from advanced cancer. Let's take a look at what the research has shown so far so you can make a more informed decision.
Lab Research vs. Human Results
Pau d'Arco has been studied in petri dishes and animal models for years. Researchers often focus on isolated compounds such as beta-lapachone. In lab settings, these compounds may affect how certain cells grow and survive.
The NQO1 Trojan Horse Mechanism (2024-2025 Research)
Recent studies from 2024 and 2025 provide more detail on how pau d'arco compounds work. Researchers focused on beta-lapachone and lapachol. They found that an enzyme called NQO1 acts like a Trojan Horse. Many cancer cells have high levels of this enzyme. When beta-lapachone enters these cells, NQO1 activates it.
Once active, the compound targets the mitochondria. Mitochondria are the energy centers of the cell. The compound disrupts how these centers work. Without energy, the cell may stop growing or die. This research helps explain the cellular process. It shows why these compounds interest scientists.
We must remember that these are cellular studies. A lab test is different from a human body. Your digestion and blood levels change how compounds behave. This research is a step forward, but it is not clinical proof for human treatment.
Tumor Reduction in Animal Studies
Researchers have tested pau d'arco extract on mice and rats. In a 2008 study, mice with tumors lived longer after receiving the extract. It also helped their immune systems recover from the stress of the disease.
Another study in 2016 looked at colorectal cancer in mice. The results showed that beta-lapachone helped reduce the spread of tumors to the lungs. It worked by triggering apoptosis. This is a process where a cell essentially shuts itself down.
In 2025, a Frontiers in Pharmacology study found that beta-lapachone inhibited cervical cancer cell proliferation and metastasis by targeting AKT1 and suppressing the PI3K/AKT/mTOR pathway. That matters because this pathway helps drive cell growth, survival, and spread. When researchers blocked it, the cancer cells became less aggressive in both lab and animal models.
A 2025 BMC Cancer study added another useful angle. In 3D breast cancer spheroids, beta-lapachone reduced tumor spheroid viability and migration. It also increased E-cadherin and decreased vimentin. Those two markers matter because they help show whether cancer cells are staying more contained or becoming more invasive. In simple terms, the findings suggest less metastatic behavior in this model.
2025 Bladder Cancer Research on Lapachol
A 2025 Scientific Reports study looked at lapachol in bladder cancer cells. Researchers found that it slowed cell growth and reduced migration. It also interfered with the cell cycle and changed non-coding RNA, ncRNA, expression. NcRNAs help regulate how genes switch on and off, so this gives researchers another clue about how lapachol may affect tumor behavior at the cellular level.
Hematopoietic Recovery and Bone Marrow Support
One older animal study also deserves attention here. In tumor-bearing mice, Tabebuia avellanedae bark extract helped reverse myelosuppression, which means bone marrow suppression caused by the cancer burden. The study found biologically active effects at 120 mg/kg, with improved hematopoietic recovery and longer survival. Researchers also compared the extract with beta-lapachone and found recovery in bone marrow related markers such as CFU-GM, which are early blood-forming cells.
This is very important if you are looking at recovery support, not just direct tumor effects. Bone marrow health affects how well your body can keep making immune cells and other blood cells during major stress. Still, this was an animal study, not a human trial.
These results in rodents are often more dramatic than what we see in humans. Animal bodies process these compounds differently than yours does. While these numbers are promising, they do not guarantee the same results for people.
Lab results do not prove the same effect in people. A petri dish is controlled. The human body is not. Digestion, absorption, dose, metabolism, and overall health all change the outcome. Many substances look promising in early lab work and then fail in human trials. That is why we need to be careful with cancer claims.
Current research does not prove that pau d'arco treats or cures cancer in humans. What it does show is that the bark contains active compounds worth studying. For now, the strongest case for pau d'arco is as a supportive wellness tea, not a stand-alone treatment.
Immune Health and the 2021 Study
A 2021 study published in Scientific Reports looked at Tabebuia impetiginosa, the species used for authentic taheebo tea. The researchers tested bark extracts on human immune cells. They found a reduction in pro-inflammatory cytokine responses.
That matters because cytokines help control immune signaling. When inflammatory signaling stays too high for too long, it can add stress to the body. The study suggests pau d'arco may help support a more balanced immune response.
This is important, but it still has limits. The study used immune cells in a research setting. It did not prove cancer outcomes in human patients. Still, it gives a useful clue about why many people use pau d'arco for immune health and recovery support.
https://taheebo-tea.com/pages/taheebo-tea-pau-darco-research
Real-World Use in Brazil
Pau d'Arco has a long history of use in Brazil. That matters because this is where the tree grows and where traditional use runs deep. One observational report looked at 387 patients who used pau d'arco alongside standard care.
An observational study is not the same as a controlled clinical trial. It cannot prove cause and effect. Still, it can show how people use a therapy in real life. In this case, the report supports what many already know, pau d'arco is often used as a complementary tea during major health challenges.
The key point is simple. Real-world use shows interest and tradition. It does not prove a medical result.
Comfort During Treatment
Memorial Sloan Kettering Cancer Center, MSKCC, has reviewed pau d'arco and its reported uses. One area they mention is oral mucositis, which means painful mouth sores that can happen during treatment.
This matters because comfort is a real issue during recovery. If a bark preparation helps reduce irritation in the mouth, that may make daily life easier for some people. Eating, drinking, and sleeping can all get harder when mucositis shows up.
We want to be careful here too. This does not mean pau d'arco fights cancer directly. It points to a possible supportive use during treatment. That is a more accurate way to describe the research.
Why Pure Inner Bark Matters
Quality matters with pau d'arco. A lot. The useful compounds are concentrated in the inner bark layer, called the phloem. That is the part used in real taheebo tea.
Some products include mostly outer bark or wood fillers. That lowers quality. It can also make the tea harsher on digestion and less consistent from batch to batch. If you are drinking pau d'arco for wellness support, you want pure inner bark, not mystery wood.
At Taheebo Wellness Tea, we focus on authentic inner bark from Brazil. No additives. No fillers. No cheap bulk material mixed in.
Safety and Side Effects
Pau d'Arco is not right for everyone. It may affect blood clotting. If you take blood thinners, antiplatelet drugs, or have a bleeding disorder, do not use it unless your doctor says it is safe.
Pregnant and breastfeeding women should avoid it. People with serious liver or kidney issues should speak with a licensed medical professional first. If you are in active treatment for cancer, ask your oncology team before adding any herb or tea.
Direct answer, yes, pau d'arco can cause side effects and drug interactions. The biggest concern is bleeding risk.
How to Brew a Strong Decoction
If you want a stronger brew, make a decoction instead of a light steep.
Use this method:
- Measure 3 tablespoons of pure pau d'arco inner bark.
- Add it to 1 quart of filtered or distilled water.
- Use a stainless steel or glass pot.
- Bring the water to a boil.
- Lower the heat.
- Simmer for 5 to 20 minutes.
- Strain and store in glass.
This method gives you a more concentrated tea than a quick steep. You can drink it warm or chilled.
Frequently Asked Questions
Does pau d'arco cure cancer?
No. Current human research does not show that pau d'arco cures cancer.
Is there any real research behind pau d'arco?
Yes. There is lab research, immune cell research, institutional review data, and observational use data. Human cancer trial data is still limited.
Why do people use pau d'arco during recovery?
Most people use it for immune support, inflammation support, digestive support, and general wellness during a stressful time.
What part of the tree should you buy?
The inner bark, also called the phloem. Avoid products padded with wood or outer bark.
Is pau d'arco safe with blood thinners?
No, not without medical approval. It may raise bleeding risk.
How much do you use for a strong brew?
Use 3 tablespoons per 1 quart of water, then boil and simmer.
For a broader look at how this supports daily wellness, see our Pau d'Arco Tea Benefits Guide.
Research on pau d'arco is still developing. Some findings are promising. Human evidence is still limited. That is why we keep the message simple. Pau d'arco may support immune health, inflammation balance, and comfort during recovery, but it is not a cure and it should never replace medical care.
If you use it, stay consistent and keep your expectations realistic. Use pure inner bark. Brew it correctly. Talk with your doctor if you take medications or have a medical condition.
We hope this guide helps you sort through the noise. If new human research comes out, we will update this page. Our goal is to give you clear information you can actually use.
Sources
Scientific Reports (2021). Tabebuia impetiginosa reduces pro-inflammatory cytokine responses in human immune cells. https://www.nature.com/articles/s41598-021-85211-8
Memorial Sloan Kettering Cancer Center. Pau d'Arco: Purported Benefits and Side Effects. https://www.mskcc.org/cancer-care/integrative-medicine/herbs/pau-darco
Observational Study (Brazil). Use of Complementary Therapies in 387 Brazilian Patients.
Journal of Ethnopharmacology. Traditional Uses and Pharmacological Activities of the Genus Tabebuia.
Frontiers in Pharmacology (2025). Beta-lapachone and mitochondrial dysfunction in cancer cells.
Cell Death & Disease (2024). NQO1-mediated oxidative stress and the Trojan Horse mechanism.
Journal of Ethnopharmacology (2008). Tabebuia avellanedae bark extract and tumor-bearing mice.
Frontiers in Pharmacology (2025). Beta-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1509568/full
Scientific Reports (2025). Lapachol interferes with the cell cycle and inhibits proliferation and migration of bladder tumor cells with effects on ncRNA expression. https://www.nature.com/articles/s41598-025-04432-3
BMC Cancer (2025). Beta-lapachone impairs viability, migration, and epithelial mesenchymal transition in mammary tumor spheroids. https://bmccancer.biomedcentral.com/article/10.1186/s12885-025-15067-y
PubMed (2008). Comparative studies of the effects of Tabebuia avellanedae bark extract and beta-lapachone on the hematopoietic response of tumour-bearing mice. https://pubmed.ncbi.nlm.nih.gov/18343063/
Let customers speak for us
What customers think about the store
Store offers high-quality wellness tea with excellent customer service. Fast shipping, responsive support, and helpful brewing guidance. Customers report significant health improvements including increased energy, better sleep, reduced inflammation, and digest...
